Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
101.00
+1.65 (1.66%)
At close: Jun 15, 2026, 4:00 PM EDT
100.80
-0.20 (-0.20%)
After-hours: Jun 15, 2026, 5:33 PM EDT
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $6.16 billion as of June 15, 2026. Its market cap has increased by 179.67% in one year.
Market Cap
6.16B
Enterprise Value
6.10B
1-Year Change
179.67%
Ranking
Category
Stock Price
$101.00
Market Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $6.16B, an increase of 1,972.19%. That is a compound annual growth rate of 55.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 6.16B | 50.87% |
| Dec 31, 2025 | 4.08B | 105.67% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spyre Therapeutics | 7.13B |
| Vaxcyte | 7.06B |
| TG Therapeutics | 7.00B |
| Immunovant | 6.95B |
| Apogee Therapeutics | 6.64B |
| Rhythm Pharmaceuticals | 6.56B |
| Legend Biotech | 6.54B |
| Centessa Pharmaceuticals | 6.15B |